Publicaciones en colaboración con investigadores/as de Universidade Federal do Rio Grande do Norte (3)

2024

  1. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

    The Lancet Global Health, Vol. 12, Núm. 2, pp. e257-e270

2022

  1. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

    Journal of Infectious Diseases, Vol. 225, Núm. 9, pp. 1521-1532

2019

  1. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents

    New England Journal of Medicine, Vol. 381, Núm. 21, pp. 2009-2019